| Group 1 Confirmed NB n = 133 | Group 2 Possible late NB n = 19 | Group 3 Possible early NB n = 15 | Group 4 Non-NB n = 96 | Group 5 Control patients n = 17 |
---|---|---|---|---|---|
Borrelia-specific AI or Borrelia-specific anti- bodies in CSF | + | + | - | - | - |
CSF pleocytosis | + | - | + | - | - |
CSF-albumin S-albumin median, (range) | 16*** (3.4-76) | 5.5 (2.4-21) | 3.5 (0-12) | 4.3 (0-22) | n.d. |
Borrelia-specific IgG/IgM antibodies detected in serum; n, (%) | 115*** (87) | 15* (79) | 15*** (100) | 42 (44) | 0*** (0) |
Men n, (%) | 80 (60) | 14 (74) | 9 (60) | 52 (54) | 9 (53) |
Women n, (%) | 53 (40) | 5 (26) | 6 (40) | 44 (46) | 8 (47) |
Median age years, (range) | 35** (3-87) | 52 (18-76) | 7*** (2-13) | 44 (2-83) | 66* (50-72) |
Median duration of symptoms before LP; weeks, (range) | 2.4 (0-32) | 4.0 (0.1-77) | 0.7 (0.1-4.0) | 3.5 (0-730) | - |
Head/neck pain n, (%) | 77 (58) | 11 (58) | 11 (73) | 43 (45) | - |
Cranial nerve palsy n, (%) | 70 (53) | 4 (21) | 11 (73) | 13 (14) | - |
Radiculitis n, (%) | 53 (40) | 7 (37) | 0 (0) | 3 (3) | - |
Other symptom n, (%) | 9 (7) | 2 (11) | 0 (0) | 39 (41) | - |